@article {17034,
	title = {Successful high-dose calcium treatment of aluminum-induced metabolic bone disease in long-term home parenteral nutrition},
	journal = {JPEN J Parenter Enteral Nutr},
	volume = {15},
	number = {2},
	year = {1991},
	note = {Lidor, C Schwartz, I Freund, U Gazit, D eng Case Reports 1991/03/01 JPEN J Parenter Enteral Nutr. 1991 Mar-Apr;15(2):202-6.},
	pages = {202-6},
	type = {Journal Article},
	abstract = {A patient who developed severe metabolic bone disease is presented. He had received long-term home parenteral nutrition (HPN) following extensive small bowel resection after mesenteric vein thrombosis. Bone disease caused by aluminum intoxication had components of osteomalacia and low-turnover osteoporosis. Aluminum was detected at the surface of mineralized bone and was elevated in the serum, resulting in a positive deferoxamine infusion test. One year of treatment with high doses of calcium (up to 24 mEq per day) significantly diminished the patient{\textquoteright}s bone pain, increased the serum levels of calcium, abolished aluminum deposits in the mineralized trabecula, improved bone formation, and increased trabecular bone volume as assessed by repeated histomorphometric analysis.},
	keywords = {Aluminum/*adverse effects/blood/metabolism Bone Development Bone Diseases, Metabolic/*chemically induced/drug therapy/physiopathology Calcification, Physiologic Calcium/administration \& dosage/blood/*therapeutic use Deferoxamine Humans Male Middle Aged},
	issn = {0148-6071 (Print) 0148-6071 (Linking)},
	doi = {10.1177/0148607191015002202},
	url = {https://www.ncbi.nlm.nih.gov/pubmed/2051559},
	author = {Lidor, C. and Schwartz, I. and Freund, U. and Gazit, D.}
}
